Narrative Update • Jul 17
Have your own idea? Try our Stock Screener
Indian (NIFTY) Pharma Industry Analysis
UpdatedJul 18, 2026
DataAggregated Company Financials
Companies182
- 7D-0.8%
- 3M15.1%
- 1Y10.5%
- YTD15.8%
The Pharma is pretty flat in the last 7 days, but Ipca Laboratories has stood out, gaining 6.3%. The past year has been better, since the industry has gained 10% in that time. As for the next few years, earnings are expected to grow by 16% per annum.
Industry Valuation and Performance
Has the Indian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 18 Jul 2026 | ₹23.7t | ₹4.5t | ₹643.1b | 30.1x | 36.8x | 5.3x |
| Mon, 15 Jun 2026 | ₹22.3t | ₹4.5t | ₹643.1b | 28.7x | 34.7x | 5x |
| Wed, 13 May 2026 | ₹21.6t | ₹4.4t | ₹630.4b | 28.6x | 34.2x | 4.9x |
| Fri, 10 Apr 2026 | ₹20.1t | ₹4.3t | ₹621.1b | 27.1x | 32.4x | 4.6x |
| Sun, 08 Mar 2026 | ₹20.4t | ₹4.3t | ₹621.2b | 26.2x | 32.9x | 4.7x |
| Tue, 03 Feb 2026 | ₹19.4t | ₹4.3t | ₹611.7b | 27.8x | 31.8x | 4.6x |
| Thu, 01 Jan 2026 | ₹20.4t | ₹4.2t | ₹614.5b | 28.6x | 33.2x | 4.8x |
| Sat, 29 Nov 2025 | ₹20.7t | ₹4.2t | ₹612.9b | 29.3x | 33.8x | 4.9x |
| Mon, 27 Oct 2025 | ₹20.4t | ₹4.1t | ₹593.7b | 30.2x | 34.3x | 5x |
| Wed, 24 Sep 2025 | ₹20.4t | ₹4.1t | ₹587.9b | 31.8x | 34.8x | 5x |
| Fri, 22 Aug 2025 | ₹20.5t | ₹4.1t | ₹589.0b | 30.7x | 34.8x | 5x |
| Sun, 20 Jul 2025 | ₹21.0t | ₹4.0t | ₹594.3b | 33.3x | 35.3x | 5.3x |
| Tue, 17 Jun 2025 | ₹20.5t | ₹4.0t | ₹595.3b | 32.7x | 34.4x | 5.1x |
| Thu, 15 May 2025 | ₹19.5t | ₹3.9t | ₹569.4b | 31x | 34.3x | 5x |
| Sat, 12 Apr 2025 | ₹18.8t | ₹3.9t | ₹559.2b | 27.6x | 33.6x | 4.8x |
| Mon, 10 Mar 2025 | ₹18.7t | ₹3.9t | ₹559.4b | 28.4x | 33.5x | 4.8x |
| Wed, 05 Feb 2025 | ₹19.8t | ₹3.9t | ₹543.4b | 31.3x | 36.5x | 5.1x |
| Fri, 03 Jan 2025 | ₹21.5t | ₹3.8t | ₹527.0b | 36.1x | 40.8x | 5.6x |
| Sun, 01 Dec 2024 | ₹20.7t | ₹3.8t | ₹526.7b | 34.1x | 39.3x | 5.4x |
| Tue, 29 Oct 2024 | ₹20.8t | ₹3.7t | ₹495.0b | 38.3x | 42.1x | 5.6x |
| Thu, 26 Sep 2024 | ₹21.6t | ₹3.7t | ₹492.6b | 41.6x | 43.8x | 5.8x |
| Sat, 24 Aug 2024 | ₹20.7t | ₹3.7t | ₹492.4b | 37.7x | 42.1x | 5.6x |
| Mon, 22 Jul 2024 | ₹18.5t | ₹3.6t | ₹454.8b | 34.3x | 40.6x | 5.1x |
| Wed, 19 Jun 2024 | ₹17.7t | ₹3.6t | ₹448.3b | 32.9x | 39.4x | 4.9x |
| Fri, 17 May 2024 | ₹17.0t | ₹3.5t | ₹435.0b | 34.7x | 39.1x | 4.8x |
| Sun, 14 Apr 2024 | ₹16.8t | ₹3.5t | ₹418.9b | 32.7x | 40.2x | 4.8x |
| Tue, 12 Mar 2024 | ₹17.0t | ₹3.5t | ₹418.7b | 32.8x | 40.6x | 4.9x |
| Thu, 08 Feb 2024 | ₹16.7t | ₹3.4t | ₹411.8b | 34.8x | 40.4x | 4.9x |
| Sat, 06 Jan 2024 | ₹15.5t | ₹3.4t | ₹395.9b | 34.2x | 39.3x | 4.6x |
| Mon, 04 Dec 2023 | ₹14.3t | ₹3.4t | ₹395.1b | 31.6x | 36.2x | 4.2x |
| Wed, 01 Nov 2023 | ₹12.8t | ₹3.3t | ₹373.9b | 29.4x | 34.2x | 3.9x |
| Fri, 29 Sep 2023 | ₹13.0t | ₹3.3t | ₹369.5b | 29.8x | 35.1x | 4x |
| Sun, 27 Aug 2023 | ₹12.8t | ₹3.3t | ₹367.0b | 29.1x | 35x | 3.9x |
| Tue, 25 Jul 2023 | ₹12.3t | ₹3.2t | ₹342.4b | 26.1x | 35.9x | 3.9x |
Price to Earnings Ratio
35.9x
Current Industry PE
- Investors are relatively neutral on the Indian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 36.6x.
- The industry is trading close to its 3-year average PS ratio of 4.9x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 23% per year over the last three years.
- Revenues for these companies have grown 12% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | -0.22% | |
| Healthcare | -0.28% | |
| Pharma | -0.79% | |
| Pharma | -0.79% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| IPCALAB Ipca Laboratories | ₹1.90k | 6.3% +₹28.6b | 29.2% | PE42.3x | |
| 500488 Abbott India | ₹28.01k | 3.3% +₹18.9b | -18.0% | PE38.4x | |
| ACUTAAS Acutaas Chemicals | ₹3.62k | 6.4% +₹17.9b | 200.8% | PE83.2x | |
| WOCKPHARMA Wockhardt | ₹1.90k | 5.0% +₹14.6b | 7.1% | PE145x | |
| 530019 Jubilant Pharmova | ₹1.02k | 6.4% +₹9.7b | -17.2% | PE40.6x |
